Arcturus Therapeutics Holdings Inc. Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arcturus Therapeutics Holdings Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Arcturus Therapeutics Holdings Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$33.4M, a 82.8% decline year-over-year.
  • Arcturus Therapeutics Holdings Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$95.7M, a 22.3% decline year-over-year.
  • Arcturus Therapeutics Holdings Inc. annual Operating Income (Loss) for 2024 was -$95.7M, a 22.3% decline from 2023.
  • Arcturus Therapeutics Holdings Inc. annual Operating Income (Loss) for 2023 was -$78.2M, a 742% decline from 2022.
  • Arcturus Therapeutics Holdings Inc. annual Operating Income (Loss) for 2022 was $12.2M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$95.7M -$17.5M -22.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$78.2M -$90.4M -742% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $12.2M +$215M Jan 1, 2022 Dec 31, 2022 10-K 2025-03-06
2021 -$203M -$131M -184% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$71.5M -$46M -180% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$25.5M -$3.7M -17% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$21.8M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.